FDA Coronavirus (COVID-19) Update: August 21th, 2020
August 21, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA has released a temporary industry guidance entitled, “Manufacturing, Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers.”
FDA Coronavirus (COVID-19) Update: August 20th, 2020
August 20, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued the third Emergency Use Authorization (EUA) for a COVID-19 Coronavirus antigen test.
FDA Coronavirus (COVID-19) Update: August 19th, 2020
August 19, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA is providing two new flowcharts and supporting information on respirators:
FDA Coronavirus (COVID-19) Update: August 17th, 2020
August 18, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued Yale School of Public Health an emergency use authorization (EUA) for its SalivaDirect COVID-19 Coronavirus diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 Coronavirus.
FDA Coronavirus (COVID-19) Update: August 15th, 2020
August 15, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has taken the following actions in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA is providing a device shortage list as part of the implementation of section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
August 14, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
FDA Coronavirus (COVID-19) Update: August 13th, 2020
August 13, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Today, the FDA published an online Consumer Update with tips on how we can each take some simple steps to help slow the spread of the coronavirus disease and protect ourselves, our families and our communities.
FDA Coronavirus (COVID-19) Update: August 11th, 2020
August 11, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
As part of the FDA’s effort to protect consumers, the agency issued a warning letter to one firm for selling unapproved products with fraudulent COVID-19 Coronavirus claims.
FDA Coronavirus (COVID-19) Update: August 8th, 2020
August 8, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has taken the following actions in its ongoing response effort to the COVID-19 Coronavirus pandemic:
On August 6th, the FDA revoked the emergency use authorization (EUA) for Autobio Diagnostics Co., Ltd.’s, Anti-SARS-CoV-2 Rapid Test, a SARS-CoV-2 antibody test, due to performance concerns with the accuracy of the test.
FDA Coronavirus (COVID-19) Update: August 7th, 2020
August 7, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic.











